Press release
Liquid Biopsy Market 2018 to 2022 Along with Guardant Health, Trovagene, RainDance Technologies, Agena Bioscience., Admera Health, etc. by MRFR
Complete Study of “Liquid Biopsy Market” Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the Liquid Biopsy Market. Forecast till 2022
Liquid Biopsy Market - Overview
Market Research Future (MRFR) The global liquid biopsy market currently values around USD 3950 million and is projected to reach the valuation of USD 17,372.28 million by 2022. This striking growth will be accompanied by a noteworthy CAGR of 28% during the forecast period (2016-2022). Liquid biopsy is a plasma genotyping technique that provides overview of karyotypic abnormalities in the circulating tumor cells present in the blood sample. In simple words, it is a test done on a blood sample to look for cancer cells from a tumor circulating in the blood.
Request Premium Sample Copy at www.marketresearchfuture.com/sample_request/710
Industry Trends:
Promising technological advancements to increase the market size
July 2018 – Exosomics Siena S.p.A. recently launched its first proprietary liquid biopsy technologies, SeleCTEV DNA and SortEV RNA. These technologies are used for the selective isolation of tumor-derived nucleic acids from complex biofluids, for instance, plasma or serum.
This is an instance of technological innovations in the context of liquid biopsy. The trend of constant efforts on the part of market players is significantly impacting the market size to a large extent.
Drivers and restraints:
High success rate of diagnosis to fuel demand for liquid biopsy
Over the course of time, liquid biopsy has been estimated to become the first line of diagnosis for a broad range of cancers such as central nervous system (CNS) and pancreatic cancer. With rapid enhancements in next-generation sequencing (NGS) technology, liquid biopsies are projected to take prime position in the context of cancer-related probe and investigation.
The global market for liquid biopsy has been positively influenced by increasing cancer awareness and incidences. Alongside growing awareness is the growth of medical tourism along with modernization of healthcare infrastructure. Favorable government policies and initiatives assist the market to tread its way upward.
Liquid Biopsy Market - Segmentation:
The global liquid biopsy market is segmented based on biomarker type, application, sample, and end-user.
Get Prime Discount at https://www.marketresearchfuture.com/check-discount/710
Sub-segment of circulating tumor cells leading the biomarker segment:
The biomarker segment comprises circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vehicles (Evs) and others. Circulating tumor cells tests are applicable in characterization of tumor cells through biochemical marker analysis. Hence, the segment is expected to dominate in terms of market share and revenue contributing close to 55.48% of the market share during the review period.
Cancer therapeutic application poised to capture considerable market share in coming years:
By application, the market is segmented on the basis of cancer therapeutic application, reproductive health, and other therapeutic application. With the rising incidence of cancer across the globe, the cancer therapeutic segment is poised to claim a sizeable share in the market throughout the appraisal period by capturing 82.83% market share of the overall market.
Blood sampling is the most frequently used sample for liquid biopsy:
By sample, the market is segmented into blood, urine, and others. On account of numerous preexisting applications and methods for purification, blood sampling is the most favorable method for liquid biopsy studies. Cell-free DNA, circulating tumor cells, and exosomes can be detected in blood sample. These factors result in higher adoption rate of liquid biopsy through blood sampling.
Hospitals and laboratories segment to grow at a strong CAGR during review period:
By end-user, the global market is segmented into hospitals and laboratories, academic and research centers and others. Among these, the hospitals and laboratories segment is expected to attract the largest revenue from 2016 to 2022.
Liquid Biopsy Market - Regional Analysis:
On the basis of region, the global liquid biopsy market is spread across North America, Europe, Asia Pacific (APAC) and the Middle East and Africa.
North America market to continue its dominance throughout the review period
Globally North America was the owner of market share of 37.95% in 2016 and will continue holding the largest market share owing to high prevalence of colorectal cancer and growing number of patients. Moreover, the region notes successful market performance due to growing demand for non-invasive procedures and strong government policies.
On the other hand, Europe is the second-largest market on account of novel clinical trials and technological advancements in the field. The region also observes growing cases of cancer that leads to massive demand for liquid biopsy procedures.
APAC has turned out to be the show stealer with the market growing at the highest rate of 28.8% in the foreseeable future. This growth has been possible due to the increasing focus of market players on this region. India and China are the emerging countries in the region with increased market access of each country’s population to healthcare resources. Other countries such as Japan, Australia and South Korea are major contributors of this market growth.
Get Customized Report with niche Segments, Vital Players and Overall Segments at https://www.marketresearchfuture.com/enquiry/710
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Liquid Biopsy Market - Overview
Market Research Future (MRFR) The global liquid biopsy market currently values around USD 3950 million and is projected to reach the valuation of USD 17,372.28 million by 2022. This striking growth will be accompanied by a noteworthy CAGR of 28% during the forecast period (2016-2022). Liquid biopsy is a plasma genotyping technique that provides overview of karyotypic abnormalities in the circulating tumor cells present in the blood sample. In simple words, it is a test done on a blood sample to look for cancer cells from a tumor circulating in the blood.
Request Premium Sample Copy at www.marketresearchfuture.com/sample_request/710
Industry Trends:
Promising technological advancements to increase the market size
July 2018 – Exosomics Siena S.p.A. recently launched its first proprietary liquid biopsy technologies, SeleCTEV DNA and SortEV RNA. These technologies are used for the selective isolation of tumor-derived nucleic acids from complex biofluids, for instance, plasma or serum.
This is an instance of technological innovations in the context of liquid biopsy. The trend of constant efforts on the part of market players is significantly impacting the market size to a large extent.
Drivers and restraints:
High success rate of diagnosis to fuel demand for liquid biopsy
Over the course of time, liquid biopsy has been estimated to become the first line of diagnosis for a broad range of cancers such as central nervous system (CNS) and pancreatic cancer. With rapid enhancements in next-generation sequencing (NGS) technology, liquid biopsies are projected to take prime position in the context of cancer-related probe and investigation.
The global market for liquid biopsy has been positively influenced by increasing cancer awareness and incidences. Alongside growing awareness is the growth of medical tourism along with modernization of healthcare infrastructure. Favorable government policies and initiatives assist the market to tread its way upward.
Liquid Biopsy Market - Segmentation:
The global liquid biopsy market is segmented based on biomarker type, application, sample, and end-user.
Get Prime Discount at https://www.marketresearchfuture.com/check-discount/710
Sub-segment of circulating tumor cells leading the biomarker segment:
The biomarker segment comprises circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vehicles (Evs) and others. Circulating tumor cells tests are applicable in characterization of tumor cells through biochemical marker analysis. Hence, the segment is expected to dominate in terms of market share and revenue contributing close to 55.48% of the market share during the review period.
Cancer therapeutic application poised to capture considerable market share in coming years:
By application, the market is segmented on the basis of cancer therapeutic application, reproductive health, and other therapeutic application. With the rising incidence of cancer across the globe, the cancer therapeutic segment is poised to claim a sizeable share in the market throughout the appraisal period by capturing 82.83% market share of the overall market.
Blood sampling is the most frequently used sample for liquid biopsy:
By sample, the market is segmented into blood, urine, and others. On account of numerous preexisting applications and methods for purification, blood sampling is the most favorable method for liquid biopsy studies. Cell-free DNA, circulating tumor cells, and exosomes can be detected in blood sample. These factors result in higher adoption rate of liquid biopsy through blood sampling.
Hospitals and laboratories segment to grow at a strong CAGR during review period:
By end-user, the global market is segmented into hospitals and laboratories, academic and research centers and others. Among these, the hospitals and laboratories segment is expected to attract the largest revenue from 2016 to 2022.
Liquid Biopsy Market - Regional Analysis:
On the basis of region, the global liquid biopsy market is spread across North America, Europe, Asia Pacific (APAC) and the Middle East and Africa.
North America market to continue its dominance throughout the review period
Globally North America was the owner of market share of 37.95% in 2016 and will continue holding the largest market share owing to high prevalence of colorectal cancer and growing number of patients. Moreover, the region notes successful market performance due to growing demand for non-invasive procedures and strong government policies.
On the other hand, Europe is the second-largest market on account of novel clinical trials and technological advancements in the field. The region also observes growing cases of cancer that leads to massive demand for liquid biopsy procedures.
APAC has turned out to be the show stealer with the market growing at the highest rate of 28.8% in the foreseeable future. This growth has been possible due to the increasing focus of market players on this region. India and China are the emerging countries in the region with increased market access of each country’s population to healthcare resources. Other countries such as Japan, Australia and South Korea are major contributors of this market growth.
Get Customized Report with niche Segments, Vital Players and Overall Segments at https://www.marketresearchfuture.com/enquiry/710
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
